ImiDomics, Gossamer Bio Form Immune-Mediated Inflammatory Disease Alliance

Feb 03, 2020

|

NEW YORK — ImiDomics said on Monday that it has partnered with drug developer Gossamer Bio on the discovery and development of new treatments for immune-mediated inflammatory diseases (IMID), beginning with inflammatory bowel disease.

ImiDomics has developed a platform that analyzes clinical and molecular data derived from an immune-mediated inflammatory disease biobank at Vall d’Hebron University Hospital in Spain to generate insights into disease biology.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Cost of a Visa

The Guardian reports that visa costs could prevent scientists and others from coming to the UK.

Rethinking Access Order

The Trump Administration is reconsidering its plan to issue an executive order to require federally funded research to be freely available upon publication, Times Higher Education reports.

May Have to Close

Nature News says some preprint repositories may close down due to a lack of funds to cover costs.

Nature Papers Present Way to Analyze Cancer Mutational Signatures, Explore Treatment Resistance in Lung Cancer, More

In Nature this week: framework for analyzing cancer mutational signatures, treatment resistance in small cell lung cancer followed by increased intratumoral heterogeneity, and more.

Featured White Papers

A Machine-Learning Framework for Accurate Classification and Quantification of Oncogenic Variants Using the QuantideX NGS DNA Hotspot 21 Kit

Powering Precision Medicine at Apollo Genetics: A GenomeWeb eCase Study Transcript

Accelerating Genomic Discoveries for Precision Medicine

Advancing Genomics in the Age of Big Data with GPU Acceleration

Mar

18

Featured Webinar

Comparison of Genome-Wide versus Targeted cfDNA Testing for First-Line Prenatal Screening: Real-World Data

This webinar will discuss data from a recent real-world comparison study evaluating performance of two cell-free DNA methodologies as first-line prenatal screens.

Mar

31

Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

Menu

ImiDomics, Gossamer Bio Form Immune-Mediated Inflammatory Disease Alliance

To read the full story....

Breaking News

Illumina Seeks Preliminary Injunction Against BGI in US Patent Infringement Case

Namocell, Takara Bio, HepaTx Partner on Single-Cell Genomics for Late-Stage Liver Disease

Ancestors of Neanderthals, Denisovans Interbred With 'Superarchaic' Hominin

DNA Methylation at Certain Sites May Have Causal Effect on Lung Function, Study Finds

BC Centre for Disease Control Launches Genomic Study to Track SARS-CoV-2

FDA Releases List of Evidence-Based PGx Variants